Happy to share our latest publication!
We have tried to establish some crucial risk factors for the development of non-hodgkin lymphoma in patients with autoimmune diseases
@ShriyaGoyal5@ShivaniMD@Saloni2509 @stpbystpgrowth @UpasanaAgrawal_
https://t.co/ooj9sFw2b6
"Honored to present two posters at #ASCO2024! Exciting discussions and insights into ‘RCC in Post Transplant patients’ and ‘Asciminib related cardiovascular side effects’. Grateful for the opportunity to contribute to the ongoing advancements in oncology. @ASCO@hemeoncfellow
An interesting case of Moyamoya disease caused by Asciminib started this study. Looking forward to meet you all to discuss more and come up with some more ideas for future collaborations🤩#ASCO24#fellowshipmatch2024@HemOncFellows@ASCO
Excited to present our research on Renal cell carcinoma and looking forward to getting valuable inputs and ideas for future collaboration🤩#ASCO24#fellowshipmatch2024@HemOncFellows@ASCO
As cancer patients live longer non-cancer related mortality becomes an important issue to address …
Read our study on outcomes of acute MI in RCC patients here
@RoboDoctr@ShivaniMD@mehndz@Saloni2509
https://t.co/MKj1dHtm9o
Thank you @accpchest for an enriching experience. Glad to have got an opportunity to present three posters and one rapid fire oral presentation at CHEST 2023 annual conference. Congratulations to the entire team🎉@SChenspeaks@ShivaniMD
I had a blast at my first ASCO meeting by getting an opportunity to meet all these dazzling minds. Looking forward to meet you again and collaborate in some of the amazing work you all are doing. #ASCO2023@jatwanikaran@chirayumohin@DevikaDasMD @DianaFranco713 @msalmanfaisal